Literature DB >> 1555437

Spontaneous pulmonary hemorrhage following coronary thrombolysis.

P E Nathan1, A V Torres, A J Smith, A J Gagliardi, K B Rapeport.   

Abstract

Excessive bleeding is a major concern during the administration of thrombolytic therapy. Although the great majority of these events occur at sites of vascular interruption, major gastrointestinal, retroperitoneal, genitourinary, and central nervous system hemorrhage are known to occur. We present a patient who developed spontaneous pulmonary hemorrhage during thrombolytic therapy. Lack of recognition that the lungs too may be a site of spontaneous hemorrhage during thrombolytic therapy may lead to a considerable diagnostic and therapeutic delay. Pulmonary hemorrhage should be considered in the differential diagnosis of patients who receive thrombolytic therapy in whom new roentgenographic pulmonary infiltrates present accompanied by decreases in hematocrit value.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555437     DOI: 10.1378/chest.101.4.1150

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Diffuse pulmonary hemorrhage after fibrinolytic therapy for acute myocardial infarction in a cocaine abuser patient.

Authors:  Mohammad Parsa Mahjoob; Isa Khaheshi; Koosha Paydary
Journal:  Heart Views       Date:  2014-07

2.  Fatal Hemoptysis during Coronary Thrombolysis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  Pulmonary haemorrhage following thrombolysis with streptokinase in myocardial infarction.

Authors:  Krishna Prasad; Parminder Singh; Kewal Kanabar; Rajesh Vijayvergiya
Journal:  BMJ Case Rep       Date:  2020-01-23

4.  Pulmonary alveolar hemorrhage following thrombolytic therapy.

Authors:  Santhosh Narayanan; N K Thulaseedharan; Gomathy Subramaniam; Geetha Panarkandy; Narayanan Arathi
Journal:  Int Med Case Rep J       Date:  2017-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.